22 related articles for article (PubMed ID: 29984433)
1. Regulation of amyloid-β levels by matrix metalloproteinase-2/9 (MMP2/9) in the media of lung cancer cells.
Dorandish S; Williams A; Atali S; Sendo S; Price D; Thompson C; Guthrie J; Heyl D; Evans HG
Sci Rep; 2021 May; 11(1):9708. PubMed ID: 33958632
[TBL] [Abstract][Full Text] [Related]
2. Cullin 4B Ubiquitin Ligase Is Important for Cell Survival and Regulates TGF-β1 Expression in Pleural Mesothelioma.
Kreienbühl J; Changkhong S; Orlowski V; Kirschner MB; Opitz I; Meerang M
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686215
[TBL] [Abstract][Full Text] [Related]
3. Level of mesothelin expression can indicate the prognosis of malignant pleural mesothelioma.
Feng F; Zhang H; Zhang Y; Wang H
Transl Cancer Res; 2020 Dec; 9(12):7479-7485. PubMed ID: 35117348
[TBL] [Abstract][Full Text] [Related]
4. Unravelling the Network of Nuclear Matrix Metalloproteinases for Targeted Drug Design.
Frolova AS; Petushkova AI; Makarov VA; Soond SM; Zamyatnin AA
Biology (Basel); 2020 Dec; 9(12):. PubMed ID: 33352765
[TBL] [Abstract][Full Text] [Related]
5. Targeting SRC Family Kinases in Mesothelioma: Time to Upgrade.
Indovina P; Forte IM; Pentimalli F; Giordano A
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664483
[No Abstract] [Full Text] [Related]
6. CO-Releasing Molecule (CORM)-3 Ameliorates Spinal Cord-Blood Barrier Disruption Following Injury to the Spinal Cord.
Zheng G; Zheng F; Luo Z; Ma H; Zheng D; Xiang G; Xu C; Zhou Y; Wu Y; Tian N; Wu Y; Zhang T; Ni W; Wang S; Xu H; Zhang X
Front Pharmacol; 2020; 11():761. PubMed ID: 32581781
[TBL] [Abstract][Full Text] [Related]
7. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.
Kodama T; Koma YI; Arai N; Kido A; Urakawa N; Nishio M; Shigeoka M; Yokozaki H
Lab Invest; 2020 Sep; 100(9):1140-1157. PubMed ID: 32457351
[TBL] [Abstract][Full Text] [Related]
8. Non-canonical Expression of Cardiac Troponin-T in Neuroendocrine Ethmoid Sinus Carcinoma Following Immune Checkpoint Blockade.
Tsuruda T; Sato Y; Kajihara K; Kawabata T; Kubuki Y; Komaki S; Kikuchi M; Ishikawa T; Tono T; Kitamura K
Front Cardiovasc Med; 2019; 6():124. PubMed ID: 31508427
[TBL] [Abstract][Full Text] [Related]
9. AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-κB, HIF1α, MMP2, and MMP9 upregulation.
Li H; Lu S; Chen Y; Zheng L; Chen L; Ding H; Ding J; Lou D; Liu F; Zheng B
Cell Signal; 2019 Jun; 58():99-110. PubMed ID: 30877036
[TBL] [Abstract][Full Text] [Related]
10. Adenosine diphosphate regulates MMP2 and MMP9 activity in malignant mesothelioma cells.
Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
Ann N Y Acad Sci; 2018 Nov; 1431(1):72-84. PubMed ID: 29984433
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ZL55 cell proliferation by ADP via PKC-dependent signalling pathway.
Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
J Cell Physiol; 2018 Mar; 233(3):2526-2536. PubMed ID: 28777435
[TBL] [Abstract][Full Text] [Related]
12. ADP sensitizes ZL55 cells to the activity of cisplatin.
Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
J Cell Physiol; 2019 Apr; 234(4):4409-4417. PubMed ID: 30144378
[TBL] [Abstract][Full Text] [Related]
13. Praeruptorin-B Inhibits 12-O-Tetradecanoylphorbol-13-Acetate-Induced Cell Invasion by Targeting AKT/NF-κB via Matrix Metalloproteinase-2/-9 Expression in Human Cervical Cancer Cells.
Hung CY; Lee CH; Chiou HL; Lin CL; Chen PN; Lin MT; Hsieh YH; Chou MC
Cell Physiol Biochem; 2019; 52(6):1255-1266. PubMed ID: 31026389
[TBL] [Abstract][Full Text] [Related]
14. Differences in the Relative Abundance of ProBDNF and Mature BDNF in A549 and H1299 Human Lung Cancer Cell Media.
Dorandish S; Atali S; Ray R; Al Khashali H; Coleman KL; Guthrie J; Heyl D; Evans HG
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209215
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
